Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Intimation Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015. (Update In Previous Authorization)

Pursuant to Regulation 30(5) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, We are hereby disclosing the updated contact details of Key Managerial Personnel (KMP) who has been authorized by the Board of Directors at their meeting held on 23 October 2021 of the Company for the purpose of determining materiality of an event or information and of making disclosure of such material information to the stock exchange under these regulations are as stated follows: Sr.No Name of KMP Designation Contact Details 01. Mr.Ajay Mansukhlal Patel Whole-time Director Email:[email protected] Contact no:+91 75748 48533 / 34 02 Mr. Chintan Nitinumar Shah Managing Director Email:[email protected] Contact no:+91 75748 48533 / 34 Kindly take the above disclosure on your records.
23-10-2021
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Un-Audited Consolidated And Standalone Financial Results For The Quarter And Half Year Ended 30 September 2021.

We are enclosing herewith, the un-audited consolidated and standalone financial results of the Company along with limited review report for the quarter and half year ended 30 September 2021, which have been approved and taken on record at a meeting of the Board of Directors of the Company held today. The above information is also available on the website of the Company: www.tatvachintan.com
23-10-2021
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 23 October 2021

We wish to inform that the Board of Directors of the Company at its meeting held today i.e., 23 October 2021, has approved the unaudited financial results of the Company (both standalone and consolidated) prepared in accordance with Indian Accounting Standards (IndAS) for the quarter and half year ended as on 30 September 2021. A copy of the said Financial Results together with Limited review report are enclosed herewith. The Board meeting commenced at 11.30 am and concluded at 3.00 pm.
23-10-2021
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, we would like to inform you that the Earnings Call post announcement of financial results of the Company for the quarter and half year ended 30 September 2021, is scheduled on Monday, 25 October 2021 at 16:00 hours (IST). The Call is hosted by B&K; Securities India Private Limited and an invite in this regard is attached for your information and records.
21-10-2021
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Board Meeting Intimation for Prior Intimation Of Board Meeting

Tatva Chintan Pharma Chem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2021 ,inter alia, to consider and approve Dear Sir/Madam, Sub: Prior Intimation of Board Meeting Pursuant to the Regulation 29 (1) (a) read with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, we hereby inform you that the Meeting of the Board of Directors of Tatva Chintan Pharma Chem Limited is scheduled to be held on Saturday, 23 October 2021, inter alia to: 1. Consider and approve the unaudited standalone financial results of the Company for the quarter and half year ended 30 September 2021. 2. Consider and approve the unaudited consolidated financial results of the Company for the quarter and half year ended 30 September 2021. Kindly take the above information on your record.
15-10-2021
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Shareholding for the Period Ended September 30, 2021

Tatva Chintan Pharma Chem Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click here
14-10-2021
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Statement Of Investor Complaints For The Quarter Ended September 2021

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 052520 Name of the Signatory :- APURVA DUBEYDesignation :- Company Secretary and Compliance Officer
11-10-2021
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Compliance Certificate pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the quarter ended 30 September 2021
08-10-2021
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

Tatva Chintan Pharma Chem Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
01-10-2021
Bigul

Tatva Chintan Pharma Chem Ltd - 543321 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

Pursuant to Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time, please find enclosed the voting results for the business transacted at the 25th Annual General Meeting (AGM) of the members of the Company held on Wednesday, the 29th September, 2021 at 4.00 pm (IST) through Video Conference ('VC')/ Other Audio Visual means ('OAVM'). We are also enclosing the herewith the Consolidated Scrutinizers Report on the remote E-voting and E-voting held during the course of AGM. The voting results along with the Scrutinizer report is also made available on the website of the Company https://www.tatvachintan.com/ and on the website of Link Intime India Pvt Ltd., an agency appointed for the purpose of conducting the remote E-voting and E-voting held during the course of AGM.
01-10-2021
Next Page
Close

Let's Open Free Demat Account